Physician profile
Charles Thomas Maupin
NPI 1154590321
$310,973.67
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $1,898 · 2021: $76K · 2022: $184K · 2023: $37K · 2024: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $19K · Honoraria: $13K · Long Term Medical Supply Or Device Loan: $10K · Consulting Fee: $6,000 · Food and Beverage: $12.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $19,224.00 |
| Honoraria | $13,000.00 |
| Long Term Medical Supply Or Device Loan | $10,085.76 |
| Consulting Fee | $6,000.00 |
| Food and Beverage | $12.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edge Endo LLC | $171,651.58 | 2022-2024 | Edgepro, Edgepro, Edgepro |
| Biolase, INC. | $137,912.00 | 2019-2023 | Waterlase Iplus |
| Sonendo INC | $1,130.05 | 2020 | |
| Dentsply Sirona INC | $98.19 | 2019 | |
| Align Technology, INC. | $68.21 | 2021 | |
| Straumann USA LLC | $66.50 | 2021 | |
| Voco America INC. | $21.37 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.72 | 2020 | |
| Ultradent Products INC | $12.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Maupin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.